By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Curis, Inc. 

61 Moulton Street

Cambridge  Massachusetts  02138  U.S.A.
Phone: 617-876-0086 Fax: 617-876-0866



Company News
Curis, Inc. (CRIS) Announces Allowance Of U.S. Patent Covering Compounds Targeting HDAC And PI3K Activities In A Single Molecule 10/28/2014 7:11:14 AM
Curis, Inc. (CRIS) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/3/2014 7:10:41 AM
Curis, Inc. (CRIS) Announces CUDC-907 Development Program Advancements 10/2/2014 8:04:10 AM
Curis, Inc. (CRIS) To Present At Upcoming Investor Conference 8/27/2014 8:33:10 AM
Curis, Inc. (CRIS) Reports Second Quarter 2014 Financial Results 8/7/2014 8:06:15 AM
Curis, Inc. (CRIS) To Release Second Quarter 2014 Financial Results And Hold Conference Call On August 7, 2014 7/31/2014 10:18:25 AM
Curis, Inc. (CRIS) Announces Investigational New Drug Application Filing By Roche (RHHBY) To Initiate A Phase 2 Study Of Erivedge® (Vismodegib) In Idiopathic Pulmonary Fibrosis 6/23/2014 7:47:43 AM
Curis, Inc. (CRIS) To Present At The JMP Securities Healthcare Conference 6/18/2014 8:34:37 AM
Curis, Inc. (CRIS) Announces Re-Initiation Of Patient Dosing In CUDC-427 Monotherapy Clinical Trial 6/5/2014 9:27:25 AM
Curis, Inc. (CRIS) Appoints A New CEO 6/3/2014 9:13:09 AM